Genmab is a dual listed company with shares traded on the Copenhagen stock exchange in Denmark and on NASDAQ Global Select Market in the US. Click here for information on Genmab's ADR Program. Shareholders holding more than 5% or more of the shares:BlackRock, Inc.Darwin Global Management Limited* *Darwin Global Management Limited controls the voting rights on shares and ADRs held by certain investment funds and portfolios for which Darwin Global Management Limited acts as investment manager.